Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ibuprofen cymbalta?

See the DrugPatentWatch profile for Ibuprofen

Is it safe to take ibuprofen with Cymbalta (duloxetine)?

You should be cautious. Cymbalta (duloxetine) can increase bleeding risk, especially when combined with nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Using them together may raise the chance of stomach or intestinal bleeding [1].

If your clinician has told you it’s okay, it’s usually done with the lowest effective ibuprofen dose for the shortest time, and with attention to bleeding warning signs.

What side effects should I watch for if I combine them?

Call for medical help right away if you notice signs of GI bleeding or unusual bruising, such as black/tarry stools, vomiting blood or material that looks like coffee grounds, severe stomach pain, or sudden weakness/dizziness [1].

Other Cymbalta-related side effects to watch for include worsening nausea, dizziness, or changes in mood, since ibuprofen doesn’t cause those directly but the overall medication burden can make effects harder to tell apart.

Why does this combination increase bleeding risk?

Both drugs can contribute to bleeding risk in different ways. NSAIDs like ibuprofen can irritate the stomach lining and impair platelet function. Duloxetine (Cymbalta) can also affect platelet function through serotonin pathways, which can make bleeding more likely when an NSAID is added [1].

Does the risk change depending on the ibuprofen dose or how long you use it?

Yes. Higher doses of ibuprofen and longer use generally increase gastrointestinal and bleeding risk. If you only need short-term pain relief, the risk is usually lower than with frequent or high-dose use, but the combination still warrants caution [1].

What are safer alternatives for pain if I’m on Cymbalta?

For many people on duloxetine, acetaminophen (paracetamol) is often considered a lower-bleeding-risk option than ibuprofen for pain/fever, because it doesn’t work like an NSAID. Still, acetaminophen has its own safety limits (especially liver risk), so the best choice depends on your health history and other medications.

When should I avoid ibuprofen altogether with Cymbalta?

Extra caution is needed if you have a history of stomach ulcers or GI bleeding, take blood thinners (like warfarin, apixaban, rivaroxaban), take other medicines that affect bleeding (like aspirin or clopidogrel), or have certain bleeding disorders. In these cases, clinicians often avoid NSAIDs or monitor more closely [1].

Can I take ibuprofen if my Cymbalta is for nerve pain?

Pain location doesn’t change the drug interaction risk. Even if Cymbalta is prescribed for nerve pain, adding ibuprofen can still raise GI bleeding risk. The question is about the medications’ effects on bleeding and the individual risk profile [1].

Should I ask my doctor or pharmacist before using them together?

Yes, especially if you take duloxetine regularly and plan to use ibuprofen more than once, use it for more than a couple of days, or have any bleeding/GI history. A pharmacist can also check your full medication list for other interaction risks.

---

Sources

  1. https://www.drugs.com/ (Duloxetine and ibuprofen interaction and bleeding risk information)


Other Questions About Ibuprofen :

can i take low doses of ibuprofenwhilst taking blood thinners patente ibuprofeno can you take ibuprofen with ramipril space between ibuprofent eliquis und ibuprofen Is ibuprofen and motrin the same? Ibuprofen and methotrexate?

AI-Drug Label Prescribing Information Alignment Report

48
48%
Grade C

Partial

Partially Aligned

Patient Risk: Moderate

Summary

Most broad bleeding-risk and GI-bleeding concepts align with the NSAID boxed warning/warnings for CALDOLOR (ibuprofen). However, multiple claims about duloxetine-specific platelet/serotonin mechanisms, duloxetine-NSAID interaction being specific to duloxetine rather than class effect, duloxetine side effects, and acetaminophen being universally lower-bleeding-risk are not supported by the provided ibuprofen (CALDOLOR) label excerpts.


Category Scores

Contraindications
40
Partial
Warnings
65
Good
DrugInteractions
55
Partial
SpecificPopulations
30
Poor
AdverseReactions
20
Poor

Accurate Statements

The label for CALDOLOR (ibuprofen) states NSAIDs increase the risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation (which can be fatal).
BOXED WARNING; 5.2
NSAIDs/ibuprofen can cause serious GI adverse events that can occur at any time and without warning symptoms.
5.2
Elderly patients are at greater risk for NSAID-associated serious GI events.
8.5 (Geriatric Use)
CALDOLOR labeling identifies bleeding risk with concomitant anticoagulants such as warfarin (synergistic effect on bleeding).
Table 3: Clinically Significant Drug Interactions with Ibuprofen; anticoagulants such as warfarin
CALDOLOR labeling notes increased bleeding risk with interference with antiplatelet activity of aspirin and that concomitant use of CALDOLOR with analgesic doses of aspirin is not generally recommended due to increased bleeding risk.
Table 3: Clinically Significant Drug Interactions with Ibuprofen; aspirin interference; not generally recommended with analgesic doses

Unsupported Statements

Cymbalta (duloxetine) can increase bleeding risk.
Provided FDA label excerpts are for CALDOLOR (ibuprofen injection) only; no duloxetine-specific bleeding risk is supported in the supplied text.
Duloxetine-related side effects to watch for include worsening nausea, dizziness, or changes in mood.
No duloxetine adverse effect information is present in the supplied ibuprofen (CALDOLOR) prescribing information excerpts.
Duloxetine can affect platelet function through serotonin pathways.
No duloxetine mechanism or platelet/serotonin pathway discussion is supported in the supplied CALDOLOR label excerpts.
Ibuprofen does not cause worsening nausea, dizziness, or changes in mood directly.
The supplied labeling excerpts do not address ibuprofen-specific claims about nausea/dizziness/mood causality.
Higher doses of ibuprofen and longer use generally increase gastrointestinal and bleeding risk when combined with duloxetine.
While the ibuprofen boxed warning/5.2 address duration-related risk in general terms (and 5.1 explicitly for CV risk), the provided text does not support a duloxetine-specific combined-risk statement.
Acute short-term pain relief with ibuprofen generally has a lower risk than frequent or high-dose use, but the combination still warrants caution when used with duloxetine.
The provided ibuprofen label excerpts state that even short-term therapy is not without risk, and do not support a duloxetine-combination relative risk comparison.
Duloxetine can make bleeding more likely when an NSAID is added.
No duloxetine-specific interaction/bleeding statement is supported by the provided ibuprofen label excerpts.
In cases of a history of stomach ulcers or GI bleeding, use of blood thinners, or use of other medicines that affect bleeding, clinicians often avoid NSAIDs or monitor more closely.
The supplied excerpts do not support this as a general clinician practice statement.
For many people on duloxetine, acetaminophen is considered a lower-bleeding-risk option than ibuprofen.
No acetaminophen comparative bleeding-risk guidance is present in the supplied CALDOLOR labeling excerpts.

Contradictions


Important Omissions

If the claims are intended to address CALDOLOR/ibuprofen safety, the label excerpts provided do not support patient guidance about duloxetine-specific interaction signs (e.g., bruising) being tied to duloxetine specifically; instead, the label excerpts support reporting GI bleeding symptoms and cardiovascular symptoms for NSAID/CALDOLOR.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Some class-based NSAID GI-bleeding/serious bleeding risk concepts align with the CALDOLOR boxed warning and warnings. However, multiple duloxetine-specific mechanistic and interaction claims are unsupported by the provided ibuprofen prescribing information, which could mislead about which drug drives the risk.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Numerous claims attribute bleeding/platelet/serotonin and adverse effect details to duloxetine and duloxetine+NSAID combination effects without support from the provided CALDOLOR (ibuprofen injection) label excerpts.

Suggested Improvement
Restrict statements to what the ibuprofen (CALDOLOR) label supports: NSAID-associated serious GI bleeding/ulceration/perforation, timing (can occur at any time; even short-term not without risk), and label-supported interactions with anticoagulants/aspirin where excerpts are provided. Remove or qualify duloxetine-specific mechanism and duloxetine-combination-specific risk assertions unless duloxetine labeling is provided.

Drug Brand Mention Assessment

Branding Score
36
Visibility
42
Mentioned
Ranking
#1
Sentiment
20
Recommendation Status
discouraged
Brand Perception
Best Known For

NSAIDs like ibuprofen can irritate the stomach lining and impair platelet function.


Core Claims
  • Cymbalta (duloxetine) can increase bleeding risk when combined with nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
  • Using them together may raise the chance of stomach or intestinal bleeding.
  • Higher doses of ibuprofen and longer use generally increase gastrointestinal and bleeding risk.
Differentiators
  • Ibuprofen is described as irritating the stomach lining and impairing platelet function.
  • The response frames bleeding risk as related to adding an NSAID to duloxetine.

Pricing Perception: Not Mentioned